Skip to content

Clinical application of patient reported outcome based Symptom Management in Lung Cancer Surgery: A multicenter, Randomized controlled trial approach

Clinical application of patient reported outcome based Symptom Management in Lung Cancer Surgery: A multicenter, Randomized controlled trial approach

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058876
Enrollment
Unknown
Registered
2022-04-18
Start date
2022-04-10
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

intervention group:Patient Education
Control Group:None

Sponsors

Fourth Military Medical University, Dondo Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The patient is 18-75 years old, and voluntarily cooperates with the questionnaire survey; 2. ECOG score 0-2; 3. The expected life is not less than 6 months; 4. Patients with non-small cell lung cancer diagnosed by pathology (histology or cytology) after surgery (classified according to WHO in 2015) who are highly suspicious of lung cancer according to chest imaging examination and plan to undergo surgical treatment; 5. Those who have not undergone radiotherapy, chemotherapy, surgery and targeted treatment before enrollment; 6. The subject must have sufficient cardiopulmonary function for the intended pneumonectomy; 7. Main organs function normally 8. Subjects volunteered to join the study and signed the informed consent procedure, with good compliance and cooperation in follow-up.

Exclusion criteria

Exclusion criteria: 1. The patients have no ability to read and understand the survey items of the scale; 2. Symptomatic central nervous system metastasis; 3. Other malignant tumors in the past 3 years; 4. According to the true judgment of the study, there are concomitant diseases that may confuse the study results or affect the completion of the study 5. Subjects who are participating in other clinical studies or whose enrollment time is less than 4 weeks from the end of the previous clinical study (the last medication or follow-up), or who have 5 half lives of the study drug; 6. Subjects are known to have a history of abuse of psychotropic substances, alcohol abuse or drug abuse; 7. The investigator believes that there are any circumstances that may damage the subject or cause the subject to be unable to meet or perform the research requirements.

Design outcomes

Primary

MeasureTime frame
The threshold number and comprehensive score of the target symptom;

Secondary

MeasureTime frame
Andson symptom assessment scale, Chinese version, functional score;Doctor Satisfaction;Patient satisfaction;Incidence of complications;EORTC QLQ-C30 (version 3)&LC13;

Countries

China

Contacts

Public ContactGu Zhongping

Tangdu Hospital of the Fourth Military Medical University

gu-zhong-ping@163.com+86 13572289311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026